About Zhiwei Song

Dr. Zhiwei Song obtained his Ph.D. degree in Biochemistry from the University of Michigan Medical School where he studied plant lectins and protein glycosylation in cancer cells.

His post-doc work was completed in the Biology Department at Massachusetts Institute of Technology (MIT) where he studied genetic control of apoptosis using fruit fly as the model system.

After that, he worked in Professor Daniel I.C. Wang’s lab in the Biotechnology Process Engineering Center (BPEC) at MIT for one and a half years.

In 2002, Dr. Song moved to Singapore. Now he is a Senior Principal Scientist at the Bioprocessing Technology Institute (BTI) of Agency for Science, Technology and Research (A*STAR).

His research has been focused on protein glycosylation, glycoengineering of CHO cells, production and characterization of recombinant biologics including antibodies produced by his CHO glycosylation mutant cells.